首页|中药调控内质网应激改善糖尿病视网膜病变的研究进展

中药调控内质网应激改善糖尿病视网膜病变的研究进展

扫码查看
内质网应激通过调节血管生成、抑制神经变性参与糖尿病视网膜病变(diabetic retinopathy,DR)的发生与发展,调控内质网应激已成为防治DR的新靶点。中药可通过抑制内质网应激减少细胞凋亡、减轻炎症反应、抑制氧化应激,从而改善DR发展过程中的神经变性、血-视网膜屏障(blood-retinal barrier,BRB)破坏及新生血管形成,保护视网膜。但目前中药对内质网应激的调控作用及其对DR发生发展产生影响的机制尚未明确,且现有研究多停留在动物实验和体外细胞实验阶段,亟需大规模、高质量的临床试验验证其疗效,同时应进行更为深入的分子生物学和药理学研究,以明确其作用机制,为DR的防治提供更多依据。
Traditional Chinese Medicine Regulating Modulation of Endoplasmic Reticulum Stress to Ameliorate Diabetic Retinopathy
Endoplasmic reticulum stress is involved in the development of diabetic retinopathy(DR)by regulating angiogenesis and in-hibiting neurodegeneration,and the regulation of endoplasmic reticulum stress has become a new target for the prevention and treatment of DR.By inhibiting endoplasmic reticulum stress,traditional Chinese medicine can reduce apoptosis,attenuate inflammation,and inhibit oxidative stress,thus improving neurodegeneration,blood-retinal barrier(BRB)disruption,and neovascularization in the process of DR development,and protecting the retina.However,at present,the regulatory effect of TCM on endoplasmic reticulum stress and the mechanism of its influence on the development of DR have not been clarified,and most of the existing studies remain at the stage of ani-mal experiments and in vitro cellular experiments,so it is urgent to validate its efficacy in large-scale and high-quality clinical trials,and more in-depth molecular biology and pharmacology studies should be conducted to clarify its mechanism of action,so that it can provide a more rationale for the prevention and treatment of DR.

diabetic retinopathytraditional Chinese medicineendoplasmic reticulum stressinflammatory responseoxidative stressap-optosis

陈言、单留峰、车文生、刘昱君、刘峙岐、史晓雪、冯志海

展开 >

河南中医药大学第一临床医学院,河南郑州 450000

郑州市中医院糖尿病科,河南郑州 450006

郑州人民医院中医科,河南郑州 450053

河南中医药大学第一附属医院内分泌科,河南郑州 450000

展开 >

糖尿病视网膜病变 中药 内质网应激 炎症反应 氧化应激 细胞凋亡

2025

中医学报
河南中医药大学,中华中医药学会

中医学报

影响因子:1.264
ISSN:1674-8999
年,卷(期):2025.40(1)